61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Abbott Laboratories
Open
Sector Healthcare
131.96 3.12
Overview
Share price change
24h
Min
127.91
Max
132.2
Income | 7.6B 9.2B |
|---|---|
Sales | 370M 11B |
P/E Sector Avg | 34.291 59.362 |
EPS | 1.34 |
Dividend yield | 2.087 |
Profit margin | 84.129 |
EBITDA | 265M 2.7B |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +6.45 upside |
Dividend yield Sector Avg | 2.09% 2.35% |
|---|---|
Next Earnings | 16 Apr 2025 |
Next Dividend date | 14 Feb 2025 |
Next Ex Dividend date | 11 Apr 2025 |
Market Cap | 221B |
|---|---|
Previous open | 128.84 |
Previous close | 131.96 |
News Sentiment
By Acuity
38%
62%
112 / 393 Healthcare
Technical Score
By Trading Central
Confidence
Strong Bullish Evidence
Abbott Laboratories Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Abbott Laboratories Forecast
Price Target
By TipRanks
6.45% upside
12 Months Forecast
Average 137.43 USD 6.45%
High 158 USD
Low 117 USD
Based on 15 Wall Street analysts offering 12 month price targets forAbbott Laboratories - Dist in the last 3 months.
Sentiment
By Acuity
112 / 393 Healthcare
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Abbott Laboratories
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.
